Full View

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin‐induced damage

SH Chen, HM Wu, CH Chu, SL Chen… - British journal of …, 2012 - Wiley Online Library
BACKGROUND AND PURPOSE Prevention or disease‐modifying therapies are critical for
the treatment of neurodegenerative disorders such as Alzheimer's disease, Parkinson's …
被引用次数：86 相关文章

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage.

SH Chen, HM Wu, B Ossola… - British Journal of …, 2012 - europepmc.org
Background and purpose Prevention or disease-modifying therapies are critical for the
treatment of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease …

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage

SH Chen, HM Wu, B Ossola… - British Journal of …, 2012 - researchoutput.ncku.edu.tw
Background and Purpose Prevention or disease-modifying therapies are critical for the
treatment of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease …
[HTML] nih.gov

[HTML][HTML] Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage

SH Chen, HM Wu, B Ossola… - British Journal of …, 2012 - ncbi.nlm.nih.gov
BACKGROUND AND PURPOSE Prevention or disease-modifying therapies are critical for
the treatment of neurodegenerative disorders such as Alzheimer's disease, Parkinson's …

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage

SH Chen, HM Wu, B Ossola… - British Journal of …, 2012 - pure.johnshopkins.edu
Background and Purpose Prevention or disease-modifying therapies are critical for the
treatment of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease …

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage

SH Chen, HM Wu, B Ossola… - BRITISH JOURNAL …, 2012 - nckur.lib.ncku.edu.tw
BACKGROUND AND PURPOSEPrevention or disease-modifying therapies are critical for
the treatment of neurodegenerative disorders such as Alzheimer's disease, Parkinson's …

Suberoylanilide Hydroxamic Acid, a Histone Deacetylase Inhibitor, Protects Dopaminergic Neurons from Neurotoxin-Induced Damage.

SH Chen, HM Wu, B Ossola… - British Journal of …, 2012 - researchportal.helsinki.fi
BACKGROUND AND PURPOSE Prevention or disease modifying therapies are critical for
the treatment of neurodegenerative disorders such as Alzheimer's disease, Parkinson's …

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage

SH Chen, HM Wu, B Ossola… - British journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Background and purpose Prevention or disease-modifying therapies are critical for the
treatment of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease …

[引用][C] Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage

SH Chen, HM Wu, B Ossola, N Schendzielorz… - British Journal of …, 2011 - cir.nii.ac.jp
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic
neurons from neurotoxin-induced damage | CiNii Research CiNii 国立情報学研究所 学術 …

[引用][C] Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage

SH CHEN, HM WU, X LI, JS HONG… - British journal of …, 2012 - pascal-francis.inist.fr
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic
neurons from neurotoxin-induced damage CNRS Inist Pascal-Francis CNRS Pascal and …